Literature DB >> 16518431

Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation.

S Sellathamby1, P Balasubramanian, S Sivalingam, R V Shaji, V Mathews, B George, A Viswabandya, A Srivastava, M Chandy.   

Abstract

Analysis of chimerism by polymerase chain reaction amplification of STR or VNTR has become a routine procedure for the evaluation of engraftment after allogeneic stem cell transplantation. Knowledge of the frequency of different STR or VNTR alleles in unrelated individuals in a population is useful for forensic work. In the context of HLA identical sibling bone marrow transplantation the informativeness of these markers needs to be evaluated. We evaluated five STRs (THO1, VWA, FES, ACTBP2, and F13A1) and 1 VNTR (APOB) for informativeness in stem cell transplants from HLA identical sibling donors. All four markers used individually allowed us to discriminate 20-56% of the patient donor pairs. Using a combination of all these markers along with a polymorphic marker in the beta-globin gene and the sex chromosome specific amelogenin marker, we were able to discriminate 99% of the patient donor pairs. We have established an algorithm for evaluating chimerism following HLA identical sibling donor transplants in the Indian population using molecular markers in 310 patients. Analysis of heterozygote frequencies in different populations is similar suggesting that this algorithm can be used universally for transplant centers to evaluate chimerism following allogeneic bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518431     DOI: 10.1038/sj.bmt.1705317

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

1.  Validation of chimerism in pediatric recipients of allogeneic hematopoietic stem cell transplantation (HSCT) a comparison between two methods: real-time PCR (qPCR) vs. variable number tandem repeats PCR (VNTR PCR).

Authors:  Morris Kletzel; Wei Huang; Marie Olszewski; Sana Khan
Journal:  Chimerism       Date:  2012-12-13

2.  Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.

Authors:  N A Fouzia; E S Edison; K M Lakshmi; A Korula; S R Velayudhan; P Balasubramanian; A Abraham; A Viswabandya; B George; V Mathews; A Srivastava
Journal:  Bone Marrow Transplant       Date:  2017-10-16       Impact factor: 5.483

Review 3.  Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance.

Authors:  Edmond J Yunis; Joaquin Zuniga; Viviana Romero; Emilio J Yunis
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Ezhilpavai Mohanan; John C Panetta; Kavitha M Lakshmi; Eunice S Edison; Anu Korula; Fouzia Na; Aby Abraham; Auro Viswabandya; Biju George; Vikram Mathews; Alok Srivastava; Poonkuzhali Balasubramanian
Journal:  Clin Pharmacol Ther       Date:  2018-01-17       Impact factor: 6.875

5.  Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  E Mohanan; J C Panetta; K M Lakshmi; E S Edison; A Korula; N A Fouzia; A Abraham; A Viswabandya; V Mathews; B George; A Srivastava; P Balasubramanian
Journal:  Bone Marrow Transplant       Date:  2017-05-08       Impact factor: 5.483

6.  Outcome of iron reduction therapy in ex-thalassemics.

Authors:  Fouzia N Aboobacker; Gaurav Dixit; Kavitha M Lakshmi; Anu Korula; Aby Abraham; Biju George; Vikram Mathews; Alok Srivastava
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

7.  Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts.

Authors:  Vikram Mathews; Biju George; Auro Viswabandya; Aby Abraham; Rayaz Ahmed; Abhijeet Ganapule; Eunice Sindhuvi; Kavitha M Lakshmi; Alok Srivastava
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.